Salicylic acid market seen doubling by 2030 on pharma and skincare demand

A new Allied Market Research report says the global salicylic acid market was worth $431.7 million in 2020 and could reach $886.9 million by 2030, driven by pharmaceuticals, personal care and food preservation. Asia-Pacific led the market in 2020 and is expected to stay on top through 2030.

Why it matters: - Salicylic acid is used across pharmaceuticals, skincare and food preservation, so market growth tracks demand in several consumer and industrial categories. - The projected jump from $431.7 million in 2020 to $886.9 million by 2030 points to sustained demand for aspirin production, acne treatments and cosmetic formulations. - Asia-Pacific’s lead matters because the region is expected to set the pace for both market share and growth through 2030.

What happened: - Allied Market Research released a report on the global salicylic acid market on June 10, 2026. - The report values the market at $431.7 million in 2020 and projects $886.9 million by 2030. - The forecast implies a 7.5% compound annual growth rate from 2021 to 2030. - Asia-Pacific held more than one-third of global revenue in 2020. - The pharmaceutical segment accounted for more than three-fourths of global revenue in 2020.

The details: - Preserved food and beverage demand, skincare use and pharmaceutical applications are the main growth drivers. - Salicylic acid is widely used in acne treatments, exfoliating products and pharmaceutical formulations. - The report flags consumer concerns about side effects from prolonged use as a possible drag on growth. - The pharmaceutical segment is expected to keep the top position through 2030 because of broad use in drug formulations, especially aspirin production. - The skin care segment is forecast to grow fastest, with a 9.2% CAGR through 2030. - Asia-Pacific is projected to post the highest regional growth rate, at 7.8% during the forecast period. - China, India, Japan and South Korea are supporting regional growth through industrialization, pharmaceutical manufacturing, cosmetics expansion and higher healthcare spending. - The report also covers North America, Europe, Latin America, the Middle East and Africa. - Companies listed in the market include Alfa Aesar, J.M. Loveridge Limited, Avonchem Limited, Midas Pharma GmbH, Novacyl, Solvay, Merck KGaA, Wego Chemical Group and Reagents. - Download the sample pages for the research overview. - View purchase options for the full report and statistical data.

Between the lines: - The market is being pulled by both consumer-facing demand and industrial pharmaceutical use, which makes it less dependent on a single end market. - The fastest growth in skin care suggests product innovation and rising acne-treatment demand are becoming more important than legacy uses alone. - Asia-Pacific’s dominance signals that manufacturing capacity and healthcare spending remain central to this category’s outlook. - The report’s mention of side effects shows safety perceptions could temper growth even as demand expands.

What’s next: - The market is expected to keep expanding through 2030 as pharmaceutical, cosmetics and preserved-food demand rises. - Market participants are focusing on product innovation, capacity expansion, strategic partnerships and geographic expansion. - Asia-Pacific is expected to remain the largest regional market while also recording the fastest growth. - North America, Europe, Latin America, the Middle East and Africa will remain part of the competitive global landscape.

The bottom line: - Salicylic acid is moving from a niche chemical to a broad-based growth market, with pharma and skincare doing most of the work.